Unilateral video-assisted thoracoscopic extended thymectomy offers long-term outcomes equivalent to that of the bilateral approach in the treatment of non-thymomatous myasthenia gravis. Interact CardioVasc Thorac Surg 2015;21:610-15. Unilateral video-assisted thoracoscopic extended thymectomy offers long-term outcomes equivalent to that of the bilateral approach in the treatment of non-thymomatous myasthenia gravis Abstract OBJECTIVES: Video-assisted thoracoscopic extended thymectomy (VATET) is commonly performed bilaterally to remove all the thymic tissue in the mediastinum for the surgical treatment of myasthenia gravis. We hypothesize that the therapeutic efficacy of unilateral thoracoscopic thymectomy (right-sided) is comparable to that of bilateral VATET.
INTRODUCTION
Thymectomy has been considered as an effective therapeutic strategy for myasthenia gravis (MG), as it may influence the natural course of the disease and even increase the chance of complete remission [1] . For decades, transsternal extended thymectomy, categorized as T3b by Myasthenia Gravis Foundation of America (MGFA), has been a standard choice in many institutions. Nowadays, minimally invasive thymectomy for MG has gained great popularity because of improved cosmetic outcome, less tissue damage, shorter hospital stay and lower incidence of myasthenic crisis [2] [3] [4] . To acquire a resection extent similar to T3b, we performed bilateral video-assisted thoracoscopic extended thymectomy (VATET) for non-thymomatous myasthenia gravis (NTMG) at an early stage in 31 patients. Later, a surgical technology of right-sided VATET described previously by Huang et al. [4] was developed in our institutions for the following NTMG patients. However, few studies have been conducted to ascertain if right-sided VATET may achieve satisfactory long-term outcome. With a minimum follow-up period of 36 months, 103 consecutive NTMG patients who received VATET were included to retrospectively evaluate the safety and long-term efficacy of both VATET approaches and identify the potential prognostic factors for all NTMG patients receiving thymectomy.
MATERIALS AND METHODS
From July 2007 to August 2011, 103 consecutive patients received VATET for the treatment of NTMG at the Second Affiliated Hospital of Fujian Medical University and the First Hospital of Quanzhou City. The clinical information of these patients was reviewed retrospectively with the permission of the Ethics Committee of both hospitals. The diagnosis of NTMG was based on the clinical, pharmacological and electrophysiological features, while the preoperative severity was determined according to the MGFA classification by experienced neurologists. Patients with age <18 years and the percentage of forced expiratory volume in one second <60% were excluded from the study. Inclusion criteria: (i) Class I, a diffuse symmetric enlargement of the gland with areas of fat attenuation in the anterior mediastinum, which was considered as thymic hyperplasia, was detected on chest computed tomography (CT) [5] ; (ii) Class II/III, remission or significant improvement of symptoms was achieved by anticholinesterase drugs, corticosteroids or both, and the dose of corticosteroid should be reduced to a minimal effective dose; (iii) Class IV, there were also 3 cases of refractory MG, which progressed rapidly to MG crisis and required endotracheal intubation and mechanical support. The weakness of respiratory muscles could not be relieved despite administration of intravenous corticosteroid, immunoglobulin and a high dose of pyridostigmine. Plasmapheresis was not attempted to relieve the symptoms, as it had been applied repeatedly over a long period of the disease.
Preoperative medications for MGFA class I/II/III included cholinesterase inhibitor (pyridostigmine, 90-180 mg/day) in 81 patients and oral corticosteroid (prednisolone, 5-20 mg/day) in 69 patients. For 3 patients with MGFA class IV disease, the medication regimen comprised pyridostigmine at a high dose of up to 60 mg six times per day, intravenous methylprednisolone (100-160 mg/day) and immunoglobulin (10 g/day).
Postoperative medications included a similar dose of pyridostigmine and a double to triple dose of corticosteroid (methylprednisolone, 15-80 mg/day for MGFA class I/II/III; 240-320 mg/day for MGFA class IV), when compared with those given preoperatively. As the symptoms of muscular weakness were resolved for 2-3 days postoperatively, the use of intravenous methylprednisolone could be reduced, and finally replaced by equivalent oral prednisolone when less than 40 mg per day.
A similar perioperative analgesic protocol was applied in all NTMG patients, regardless of the surgical approaches performed. A pre-emptive local blockade, infiltration anaesthesia of the intercostal nerve, was performed with the use of bupivacaine intraoperatively [6] . After the surgery, a patient-controlled analgesic system (PCA) with intravenous morphine was provided, and the fentanyl transdermal system was added when necessary.
Postoperative visits were accomplished by experienced neurologists. Follow-up visits were required on schedule at least every 3 months in the first year and every 6 months in the following years after surgery. MGFA post-intervention status was applied to assess the therapeutic efficacy of thymectomy. Complete stable remission (CSR) was defined as no symptoms or signs of MG for at least a year off treatment [1] . The clinicopathological features, including sex, age, preoperative disease duration, medications prior to surgery, MGFA classification, surgical approach, post-interventional MGFA status, morbidity, mortality and pathological diagnosis, were collected.
Surgical technique
The operation was performed under general anaesthesia after a double-lumen endotracheal tube intubation.
Bilateral VATET started with a right-sided approach. Patients were placed in a left 30°lateral decubitus position, with the right arm elevated enough out of the operative field. The first incision was made at the seventh intercostal space, posterior axillary line. Two additional 15-mm incisions were made at the third intercostal space, anterior axillary line and at the sixth intercostal space, anterior axillary line, as operative ports. Similar to Nakagiri's description [7] , the exposure of the left innominate vein and right thymic superior pole, division of the thymic vein as well as dissection of the right pericardiophrenic fat pad were accomplished from the right side. Then, followed a left-sided approach with a similar incision design, in which patients were placed in a right 30°l ateral decubitus position. The left thymic superior pole and the left pericardiophrenic fat pad were teased out from the left side.
During the right-sided VATET, we divided the right internal thoracic vein to facilitate the exposure of bilateral superior poles of the thymus, which were then teased out completely off the neck, utilizing the ultrasonic shears and endoscopic grasper alternatively. After the superior poles of the thymus were reflected caudally, the venous drainage of thymus to the left innominate vein was identified and divided. With continued effort at thymus retraction, the left lateral posterior portion of the thymus was dissected caudally anterior to the left phrenic nerve. Then, the right pericardiophrenic fat pad was teased out, while the removal of the left one needed excellent visualization by proper angulation and positioning of the 30°thoracoscope.
The resected specimens including the thymus and fatty tissues were sent for histopathological examination. A single chest tube was routinely placed in both pleural cavities, regardless of the surgical approaches, and removed postoperatively if the drainage volume was less than 150 ml. Tracheotomy was performed immediately after thymectomy in 3 patients with MGFA class IV disease, whereas other patients were extubated in the operation theatre successfully.
Statistical analysis
Continuous variables were compared by a t-test or Mann-Whitney test, depending on the distribution of the data. Categorical variables were analysed by a χ 2 test or Fisher's exact test. CSR, calculated by Life-table analysis, was applied to evaluate the efficacy of thymectomy. Kaplan-Meier curves of different surgical methods were compared by the log-rank test. Variables probably influencing the outcome were evaluated by Kaplan-Meier curves and the Cox proportional hazards regression model. A value of P < 0.05 was considered statistically significant. Statistical analysis was performed by SPSS version 19.0.
The method established by Hsieh and Lavori was applied to calculate the required sample size for the Cox proportional hazard model [8] . By applying the software STATA version 12.0, the calculated failure event (CSR) size is 39. As the estimated CSR rate is 48/103 = 0.47, the required sample size is 39/0.47 = 83. When adjusted for other covariates (other seven prognostic factors), the required sample size became 84. Therefore, we believed that a sample size of 103 was large enough to avoid a type 2 statistical error in a Cox proportional hazard analysis.
RESULTS
The first 31 patients received bilateral VATET, whereas 72 patients underwent right-sided VATET. The clinical and pathological characteristics of the bilateral VATET group and the right-sided VATET Table 1 . There were no significant differences in terms of gender, age, disease duration, MGFA class and preoperative medication. Each group had one left innominate vein injury during the operation, which was repaired successfully by extending the incision at the third intercostal space to 10-12 cm. No patient died perioperatively. The postoperative morbidity of the two groups is illustrated in Table 2 . Both cases of MG crisis, triggered by pneumonia, were reversed by non-invasive bi-level positive airway pressure assisted ventilation. Tracheotomy and mechanical ventilation were scheduled immediately after thymectomy in 3 patients with MGFA class IV disease, and weaned successfully at 5-7 days after surgery.
The surgical outcomes of the two groups are compared in Table 3 . The variables used to evaluate the operative safety and efficacy were comparable between groups, with an exception of operating time, which was significantly shorter in the right-sided VATET group (P > 0.05). The long-term outcomes, measured by estimated CSR, did not differ significantly between groups (Fig. 1) .
No patients were lost to follow-up. The median duration of follow-up was 5.2 years (range, 3.1-7.2 years). The final follow-up was done on 1 September 2014. Overall, 48 patients achieved CSR, and the 1-, 2-, 3-, 4-, 5-and 6-year CSR rates were 9, 25, 40, 45, 52 and 56%, respectively. The 5-year CSR rate of NTMG patients receiving right-sided VATET was 47%, whereasit was 52% in the bilateral VATET group (P = 0.96). No exacerbation occurred after CSR was ascertained. Univariate analysis (n = 103, 31 bilateral VATET and 72 right-sided VATET) showed that gender, age, MGFA class, preoperative medications, anti-AChR antibody and surgical approach did not correlate significantly with surgical outcome, whereas shorter disease duration prior to surgery (<12 months) and thymic hyperplasia were predictors of response to thymectomy in all NTMG patients (Table 4 and Fig. 2 ). In the Cox regression model, shorter disease duration (<12 months; P = 0.021, HR = 0.50) and thymic hyperplasia (P = 0.038, HR = 0.48) were considered as independent predictors for a higher CSR rate in 103 patients receiving thymectomy (Table 5 ).
DISCUSSION
The resection techniques for thymectomy include transcervical, transsternal, video-assisted thoracic surgery and robotic thymectomy. The sufficient extent of thymectomy and the ideal surgical approach have not been established thus far. As the complete removal of the thymus and ectopic thymic tissue has been widely accepted as a surgical goal, the combined transcervical-transsternal thymectomy (T4) is considered to be a benchmark against which other techniques are measured [9] [10] [11] . However, the resulting increased morbidity and cosmetic issues make neurologists and patients reluctant to undertake this surgery [11] . Minimally invasive thymectomy has gained great popularity recently due to the lower morbidity, shorter recovery time and improved cosmetic outcome. 
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Thoracoscopic thymectomy can be performed from either the right side or the left, and each has its proponents [4, 12, 13] . Considering the increased risk for innominate vein injury from the left side, we commonly chose the right-sided approach in our two institutions. Novellino et al. [14] first described a bilateral thoracoscopic approach with an additional cervical incision, in order to solve the technical difficulties of the unilateral approach with exposure of the superior poles and resection of the contralateral pericardiophrenic fat pads. Some surgeons believed it was possible to expose the superior poles of the thymus by the application of CO 2 insufflation and neck flexion, in the absence of a cervical incision [15, 16] . In our experience, we did not routinely perform a cervical incision and even employed CO 2 insufflation. We divided the right internal thoracic vein to facilitate the visual and surgical access to bilateral superior poles of the thymus. With the proper positioning of the thoracoscope and skilled cooperation, the resection of contralateral pericardiophrenic fat pads also became possible via a unilateral approach.
Many previous reports have confirmed the safety and surgical efficacy of bilateral VATET [2, 3, 15, 17] . In a prospective study in a single institute, bilateral VATET had longer operative time and less intraoperative blood loss than that of T3b, while the postoperative complications and extent of resection did not differ between groups [15] .
In this series, the right-sided VATET was found to be feasible and safe when compared with bilateral VATET, with respect to blood loss, pain severity, drainage time, ICU stay, hospital stay and postoperative morbidity. We also found that the mean operating time in the right-sided VATET group was significantly shorter. However, the outcome may have been biased, as the bilateral VATET cases were performed while the surgeons were still in the learning curve of thoracoscopic skills for thymectomy.
In this study, the incidence of postoperative morbidity was relatively higher (18%) when compared with previous reports [18] . A larger proportion of patients with severe diseases may contribute to the increased incidence of postoperative pneumonia. Three cases of MGFA class IV account for the higher morbidity as well, because of the immediate tracheotomy after thymectomy.
We should point out that the resection extent of both the surgical approaches in this study included dissection of bilateral superior poles of the thymus gland and almost complete removal of the fatty tissue in the anterior mediastinum, except the aortopulmonary window region. In this series, the extent of resection of rightsided VATET, evaluated by the mean wet weight of resected tissue, was proven to be similar to that of bilateral VATET (44.9 vs 46.4 g). Moreover, the specimen weights of the two groups were both comparable to that in Mantegazza's report (44.2 g), in which the bilateral thoracoscopic approach and a cervical dissection were applied [2] .
The CSR rate is an important factor, related to the long-term efficacy of thymectomy for NTMG. Actually, we found that the majority of CSRs occurred during the second and third year. Thus, a minimum follow-up period of 36 months was employed in our research. The CSR rate calculated by Kaplan-Meier analysis was 56% at 6 years in all patients who received VATET, which was similar to the long-term outcomes of other studies [2, 19] .
The 5-year CSR of NTMG patients receiving right-sided VATET was 47%, which proves the long-term efficacy of right-sided VATET when compared with bilateral VATET (P = 0.96). Huang et al. reported that the right-sided VATET group showed a trend towards a worse CSR when compared with the T3b group (42.4 vs 60.6%, P = 0.087). The inadequate surgical extent (residual fatty tissue behind the left brachiocephalic vein, surrounding the left phrenic nerve and in the left pericardiophrenic angle) may account for the worse surgical outcome [4] .
There is still no consensus on the prognostic factors potentially affecting the CSR for patients receiving thymectomy. Two independent prognostic factors were identified by the Cox proportion regression model in this study: shorter disease duration (P = 0.021, HR = 0.50) and thymic hyperplasia (P = 0.038, HR = 0.48). Our results showed that the CSR rate increased twice in earlier surgical intervention (<12 months) group, when compared with the delayed intervention group. Similar findings have been reported by other investigators [12, 19, 20] . Pompeo and colleagues [19] speculated that the increased CSR rate after earlier thymectomy was ascribed to the less damage to the neuromuscular junction of NTMG patients.
Thymic hyperplasia shown by postoperative pathological examination was another factor significantly associated with CSR, which was also confirmed in other reports utilizing Kaplan-Meier analysis to calculate remission [2, 3, 21] . Therefore, we postulate that once the key morphological feature of thymic hyperplasia, a diffuse symmetric enlargement of the gland with fat attenuation, is identified by chest CT in NTMG patients, thymectomy is recommended because of its better surgical outcome [5] .
Other prognostic factors were reported in previous studies [2, 3, 19, 21, 22] , including younger age, clinical severity classification and preoperative medications. However, they were not significantly related to the efficacy of thymectomy for NTMG patients in our series.
This was a retrospective study. Only 73% of patients were tested for serum anti-AChR-Ab levels. Seropositive patients showed a trend towards a higher CSR rate (48 vs 29%, P = 0.12). The lack of statistical difference may just be a type 2 statistical error due to incomplete data. Detection of antibody against muscle-specific receptor tyrosine kinase (anti-MuSK-Ab) was not included in this study. These were previously reported as prognostic factors for achieving CSR after thymectomy in MG patients [19, 23] .
CONCLUSIONS
The right-sided VATET is a safe operative option for NTMG patients, providing a similar extent of resection to bilateral thoracoscopic thymectomy. The long-term outcome of right-sided VATET, measured by CSR, is acceptable, when compared with that of bilateral VATET.
